Do you know…
what to do if an amendment may affect a previously approved exempt study’s status as exempt? CLICK HERE to learn more.
Categories: Tip of the Week
Home
> Tip of the Week > Do you know…
Comments (0)
Trackbacks (0)
Leave a comment
Trackback
Leave a Reply Cancel reply
Recent Posts
- FDA MedWatch – Zithromax (azithromycin): FDA Statement on risk of cardiovascular death
- FDA MedWatch – Hydromorphone Hydrochloride Injection 1 MG/ML, (C-II) 1 ML Fill In 2.5 ML Carpuject: Recall
- Did you know…
- FDA MedWatch – Morphine Sulfate Injection USP, 4 mg/mL (C-II), 1 mL fill in 2.5 mL Carpuject by Hospira, Inc: Recall
- FDA MedWatch – Altuzan (bevacizumab): Counterfeit Product
- Do you know…
- Did you know…
- Did you know…
- FDA MedWatch – Victrelis (boceprevir) and Ritonavir-Boosted Human Immunodeficiency Virus (HIV) Protease Inhibitor Drugs: Drug Safety Communication
- FDA MedWatch – Proton Pump Inhibitors (PPIs) – Drug Safety Communication
Categories
Blogroll
Archives
- May 2012
- April 2012
- March 2012
- February 2012
- January 2012
- December 2011
- November 2011
- October 2011
- September 2011
- August 2011
- July 2011
- June 2011
- May 2011
- March 2011
- February 2011
- January 2011
- December 2010
- November 2010
- October 2010
- September 2010
- August 2010
- July 2010
- June 2010
- May 2010
- April 2010
- March 2010
- February 2010
- January 2010
- December 2009
- November 2009
- October 2009
- September 2009
- August 2009
- July 2009
- June 2009
- May 2009
- April 2009
- March 2009
- February 2009
- January 2009
- December 2008
